Due 2/1/13 Pilot and Feasibility Awards
The Diabetes Research and Training Center (DRTC) announce the availability of Pilot and Feasibility awards (up to $50,000 annually for up to two years) for new projects that explore a diabetes-related concept. Basic and translational projects related to diabetes are eligible. These funds are intended to enable investigators to generate preliminary data so as to provide the basis for seeking extramural funding of their project. Pilot and feasibility funds are not intended to support or supplement ongoing diabetes research programs. Recipients are required to hold the rank of Assistant Professor or higher at the time of the award.
ELIGIBILITY (in order of priority): This program is designed to support:
1) New investigators with interests in diabetes or related metabolic and endocrine disorders. Included in this category are junior investigators shifting from mentor based research to an independent career. Meritorious applications from new investigators receive priority for funding.
2) Established Faculty in other areas who wish to apply their expertise to diabetes research
3) Diabetes Center members who wish to explore a new area of research that constitutes a substantive departure from their on-going work. .
A proposed pilot and feasibility study should present a testable hypothesis and clearly delineate the question being asked, detail the procedure to be followed, and discuss how the data will be analyzed. The budget for the first year (of a possible two-year funding period) can be up to $50,000. Salary support for the investigator is generally not provided, except under circumstances that must be pre-approved before submission. Renewal for a second year of funding is contingent on adequate progress. Recipients are required to submit a brief progress report and present their research progress at one of the weekly Diabetes Research Center “Work in Progress” Seminars.
No internal grant forms or approval signatures are necessary in order to submit an application. However, if CCI approval is needed for protection of human subjects, then applicants should apply for that approval at the time the proposal is submitted. Submit your application electronically as an e-mail attachment to firstname.lastname@example.org by February 1, 2013. Your application must include an abstract, budget, a research plan that does not exceed 5 pages, other support data, and NIH biosketches for all key personnel. Provide these components as a single Word or PDF document. Please use the NIH PHS 398 grant application forms which can be downloaded from the NIH website: http://grants1.nih.gov/grants/funding/phs398/phs398.html
The start date for funding of successful applications is anticipated to be April 1, 2013. Questions concerning this program should be directed to Dr. Norman Fleischer (email@example.com) or Dr. Streamson Chua (firstname.lastname@example.org).
Jeffrey Pessin, Ph.D.
Director, Diabetes Research Center
Due 2/15/13 Einstein Stable Isotope and Metabolism Core Facility Seed Grant
The Einstein Diabetes Center, Mount Sinai School of Medicine Metabolism Institute and Columbia Diabetes Center are pleased to announce a joint venture to provide seed grant funding for the use of the Einstein Stable Isotope & Metabolism Core facility. The Metabolism Core has been streamlined to provide specific modules to analyze various metabolites present in plasma, urine, tissue and cells. We have also established a high throughput system (Biocrates) for human plasma that can analyze 180 individual metabolites (biogenic amines, amino acids, acylcarnitines, glycerophospho/sphingolipids and hexoses) from a single well of a 96-well plate. Specific details of available modules and assays can be found at (http://www.einstein.yu.edu/research/shared-facilities/stable-isotope-metabolomics-core/).
To facilitate the use of this Core facility we are planning to fund several micro-grants ($10-15,000 each) for the specific use in the Metabolism Core. This opportunity is open to all faculty members that are interested in diabetes, obesity and related metabolism questions. The application process is very brief and should be submitted as a single pdf file by Email to email@example.com by 2/15/2013.
Please include your NIH formatted biosketch and proposal. The 2 page proposal should include:
- Introduction/Aim (1/2 page max)
- Research Project (1 page max)
- Prospect for future NIH application (1/2 page max)
No internal grant forms or approval signatures are necessary in order to submit an application.